Biocept, Inc.
BIOC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,995 | $17,829 | $17,531 | $1,997 |
| - Cash | $12,897 | $28,864 | $14,368 | $9,301 |
| + Debt | $12,109 | $12,673 | $12,229 | $2,540 |
| Enterprise Value | $2,207 | $1,638 | $15,392 | -$4,765 |
| Revenue | $25,858 | $61,249 | $27,461 | $5,529 |
| % Growth | -57.8% | 123% | 396.7% | – |
| Gross Profit | -$2,582 | $23,485 | $6,125 | -$5,449 |
| % Margin | -10% | 38.3% | 22.3% | -98.6% |
| EBITDA | -$30,328 | -$2,409 | -$14,467 | -$23,057 |
| % Margin | -117.3% | -3.9% | -52.7% | -417.1% |
| Net Income | -$32,087 | -$2,824 | -$17,042 | -$24,615 |
| % Margin | -124.1% | -4.6% | -62.1% | -445.2% |
| EPS Diluted | -56.78 | -5.73 | -43.16 | -357.41 |
| % Growth | -890.9% | 86.7% | 87.9% | – |
| Operating Cash Flow | -$13,289 | $3,690 | -$19,787 | -$23,049 |
| Capital Expenditures | -$807 | -$1,572 | -$867 | -$735 |
| Free Cash Flow | -$14,096 | $2,118 | -$20,654 | -$23,785 |